Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study
Authors
Keywords
Dementia, cilostazol, cohort studies
Journal
Neurotherapeutics
Volume 14, Issue 3, Pages 784-791
Publisher
Springer Nature
Online
2017-02-13
DOI
10.1007/s13311-017-0512-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vascular Factors in Diabetes and Alzheimer's Disease
- (2017) Akihiko Taguchi JOURNAL OF ALZHEIMERS DISEASE
- Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial
- (2016) Hiroshi Ueda et al. AMERICAN HEART JOURNAL
- Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis
- (2016) Wen Wang et al. Journal of Stroke & Cerebrovascular Diseases
- Antiplatelet Agents for the Secondary Prevention of Ischemic Stroke or Transient Ischemic Attack: A Network Meta-Analysis
- (2016) Wen Wang et al. Journal of Stroke & Cerebrovascular Diseases
- Low-dose adjunctive cilostazol in patients with complex lesions undergoing percutaneous coronary intervention
- (2015) Xin-Tian Zheng et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Phosphodiesterase Inhibitors as a Target for Cognition Enhancement in Aging and Alzheimer’s Disease: A Translational Overview
- (2014) P.R.A. Heckman et al. CURRENT PHARMACEUTICAL DESIGN
- Cilostazol Add-On Therapy in Patients with Mild Dementia Receiving Donepezil: A Retrospective Study
- (2014) Masafumi Ihara et al. PLoS One
- Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis
- (2013) Akihiko Taguchi et al. Psychogeriatrics
- Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: A pilot study
- (2012) Hirofumi Sakurai et al. Geriatrics & Gerontology International
- Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation
- (2011) Sun Haeng Park et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-platelet therapy: phosphodiesterase inhibitors
- (2011) Paolo Gresele et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cilostazol Reduces the Risk of Hemorrhagic Infarction After Administration of Tissue-Type Plasminogen Activator in a Murine Stroke Model
- (2011) Yukiko Kasahara et al. STROKE
- Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies
- (2010) B. H. Ch. Stricker et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
- (2010) Yukito Shinohara et al. LANCET NEUROLOGY
- A Combination Therapy of Donepezil and Cilostazol for Patients With Moderate Alzheimer Disease: Pilot Follow-Up Study
- (2009) Heii Arai et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now